Evidence Hub

Bilateral Pathological Femoral Fractures Secondary to Long-Term Tenofovir Disoproxil Fumarate-Induced Osteomalacia in a Woman Living with HIV: A Case Report

Jawahar Kanth JS, Okello MO, Anish TMR, Namutebi F, Namawejje P, Segawa MC, Rutakingirwa MK, Mbabazi P et al.

International medical case reports journal, 2026

Abstract

Background: People living with HIV on long-term antiretroviral therapy (ART) face increased risks of bone loss and fragility fractures, partly due to tenofovir disoproxil fumarate (TDF), a commonly used nucleoside reverse transcriptase inhibitor. TDF is associated with proximal tubular dysfunction, renal phosphate wasting, osteomalacia, and pathological fractures. This case highlights severe, bilateral femoral fractures as a rare but debilitating manifestation of chronic TDF-induced osteomalacia in a postmenopausal woman.

Case presentation: A 43-year-old African woman with HIV (diagnosed >15 years prior) presented with progressive generalized bone pain and inability to bear weight after minor trauma. She had received TDF-based ART for 12 years. One year earlier, her regimen was switched to abacavir/lamivudine/dolutegravir due to emerging bone pain. Examination revealed bilateral hip tenderness, immobility, stage-4 sacral and ischial pressure ulcers, and rectal prolapse secondary to prolonged immobility and constipation. Laboratory findings included severe hypophosphatemia (0.33 mmol/L), elevated alkaline phosphatase (320 U/L), low-normal 25-hydroxy-vitamin D, and upper-normal PTH, with normal renal function and no overt Fanconi syndrome at presentation. Pelvic radiographs confirmed bilateral pathological femoral fractures (right intertrochanteric, left subcapital). Other causes (malignancy, infection, primary metabolic disorders) were excluded. Management involved permanent…

How strong is the evidence?

Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free